We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

15 hedge funds and large institutions have $175K invested in Sonoma Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $144K → $175K (+$31.4K)

0.01% more ownership

Funds ownership: 0.16% → 0.16% (+0.01%)

12% less funds holding

Funds holding: 17 → 15 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$53.5K
2
State Street
State Street
Massachusetts
+$25K
3
Wells Fargo
Wells Fargo
California
+$21

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$23K
2
Renaissance Technologies
Renaissance Technologies
New York
-$20.3K
3
GSC
Ground Swell Capital
South Carolina
-$13K
4
ASN
Advisory Services Network
Georgia
-$2.4K
5
VF
Virtu Financial
New York
-$1.36K
Name Holding Trade Value Shares
Change 		Change in
Stake
TSS
1
Two Sigma Securities
New York
$55.7K +$53.5K +2,602 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$39.5K – – –
State Street
3
State Street
Massachusetts
$26.5K +$25K +1,216 New
Renaissance Technologies
4
Renaissance Technologies
New York
$24K -$20.3K -988 -47%
VF
5
Virtu Financial
New York
$16K -$1.36K -66 -8%
TRCT
6
Tower Research Capital (TRC)
New York
$9.18K – – –
BlackRock
7
BlackRock
New York
$3.08K – – –
US Bancorp
8
US Bancorp
Minnesota
$535 – – –
Osaic Holdings
9
Osaic Holdings
Arizona
$231 – – –
Morgan Stanley
10
Morgan Stanley
New York
$92 – – –
AF
11
Allworth Financial
California
$70 – – –
Bank of America
12
Bank of America
North Carolina
$47 – – –
Wells Fargo
13
Wells Fargo
California
$35 +$21 +1 +100%
GI
14
Gradient Investments
Minnesota
$33 – – –
NC
15
NewSquare Capital
Pennsylvania
$11 – – –
Millennium Management
16
Millennium Management
New York
– -$23K -1,179 Closed
GSC
17
Ground Swell Capital
South Carolina
– -$13K -666 Closed
ASN
18
Advisory Services Network
Georgia
– -$2.4K -123 Closed
JP Morgan Chase
19
JP Morgan Chase
New York
– -$1K -34 Closed

SNOA Hedge Fund Activity: Q2 2023 in Review

15 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q2 2023, worth a combined $175K — up 22% from $144K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SNOA and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $53.5K. The largest seller was Millennium Management, exiting entirely with an estimated $23K sold.

  • 15 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q2 2023, down from 17 in Q1 2023.
  • Funds reported $175K of Sonoma Pharmaceuticals stock for Q2 2023, up 22% quarter-over-quarter.
  • 2 funds opened new Sonoma Pharmaceuticals positions in Q2 2023 and 4 closed out, a net change of -2 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q2 2023 was Two Sigma Securities, an estimated $53.5K added.
  • The largest Sonoma Pharmaceuticals seller in Q2 2023 was Millennium Management, an estimated $23K sold.

Based on aggregated 13F filings for Q2 2023.